Supply of NIV Drugs to Directorate of Procurement (Navy), Islamabad

This tender invites bids for the supply of NIV drugs to the Directorate of Procurement (Navy) located in Islamabad. The procurement falls under Pharmaceuticals & Laboratory Supplies and is managed by the Directorate of Procurement (Navy). The tender covers a comprehensive list of medicines including tablets, capsules, and other pharmaceutical items required for the fiscal year 2026-27. The scope involves supplying medicines as per detailed specifications and quantities listed in the tender documents. The delivery location is Islamabad, with supplies to be made on a quarterly basis or as required. The tender requires firms to submit technical and commercial offers in separate sealed envelopes following a Single Stage - Two Envelope bidding procedure. The medicines must comply with national standards, have proper shelf life, and be delivered in sealed packaging with clear labeling. Inspection and quality assurance will be conducted by designated authorities including PNMSD and PNS Hafeez. Bidders must be registered with DGDP or willing to register, and must be on the Active Taxpayers List (ATL) of FBR. Earnest Money in the form of a Call Deposit Receipt (CDR) is mandatory, with rates varying by firm registration status. The tender requires compliance with PEC categories and FBR regulations for the fiscal year 2025-26. Firms should ensure all required documents including licenses, tax certificates, and audit reports are attached to avoid disqualification. The submission deadline is set for 31st March 2026 at 1030 hours, with technical bids opening at 1100 hours the same day. Offers must be delivered to the Directorate of Procurement (Navy) through Bahria Gate, Naval Residential Complex, Sector E-8, Islamabad. Late submissions will not be entertained. Pro-Tip: Ensure the Earnest Money is submitted exactly as per tender conditions and attach all required certificates including DGDP registration and ATL status. Missing or improper documentation is a common cause for rejection. Also, carefully follow the two-envelope submission process to avoid disqualification.